Glycosaminoglycans in malignant diffuse mesothelioma

Area of Science:

• Biochemistry
• Oncology
• Pathology

Background:

• Morphologic similarity between diffuse pleural mesothelioma and lung adenocarcinoma poses diagnostic challenges.
• Accurate differentiation is crucial for appropriate patient management and treatment.

Purpose of the Study:

• To investigate glycosaminoglycans (GAG) as potential biomarkers for distinguishing diffuse pleural mesothelioma from papillary adenocarcinoma of the lung.
• To compare GAG composition and quantity in mesothelioma versus lung adenocarcinoma.

Main Methods:

• Histochemical staining and chemical quantification of GAG in human malignant diffuse mesothelioma and lung adenocarcinoma.
• Two-dimensional electrophoretic separation of GAG fractions.
• Morphological confirmation of mesothelioma diagnosis.

Main Results:

• Total GAG levels were significantly elevated in mesothelioma compared to lung adenocarcinoma and pleural connective tissue.
• Hyaluronic acid was a predominant GAG fraction in mesothelioma (57% of total GAG), compared to lung adenocarcinoma (38%).
• Both mesothelioma and lung adenocarcinoma samples contained hyaluronic acid, heparan sulfate, heparin, dermatan sulfate, and chondroitin sulfate.

Conclusions:

• Chemical analysis of GAG, particularly hyaluronic acid content, may serve as a valuable supplementary diagnostic tool.
• This biochemical approach can aid in differentiating diffuse pleural mesothelioma from papillary adenocarcinoma of the lung, complementing morphological examination.